Status:
UNKNOWN
Moxibustion Reduces Symptoms and Improves Quality of Life in Patients With Allergic Rhinitis
Lead Sponsor:
Henan University of Traditional Chinese Medicine
Conditions:
Allergic Rhinitis
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The objective of this randomized controlled clinical trial is to compare the therapeutic effect of moxibustion on allergic rhinitis. The main questions it aims to answer are: Based on randomized cont...
Detailed Description
Allergic rhinitis has a high incidence and is difficult to cure, seriously affecting the quality of life of patients Compare the effects of different moxibustion durations on the clinical efficacy and...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Those who meet the diagnostic criteria of Chinese and Western medicine for AR;
- Age range from 18 to 75 years old, regardless of gender;
- Patients and their families are informed and agree to the study.
- Exclusion criteria
- Those who are undergoing other traditional Chinese medicine external treatment methods;
- Those who have taken traditional Chinese medicine recently or during treatment;
- Individuals who are allergic to heavy moxibustion smoke and dust;
- Individuals with concomitant bronchial asthma or other respiratory system diseases;
- Patients with severe skin diseases or ulcers in the local area where moxibustion is applied;
- Pregnant and lactating patients;
- Patients with severe diseases of important organs such as the heart, liver, lungs, and kidneys;
- Those who are unable to receive treatment according to regulations due to inconvenience in work, study, transportation, or personal activities
Exclusion
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06173882
Start Date
August 1 2022
End Date
August 1 2025
Last Update
December 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Henan University of Chinese Medicine
Zhengzhou, China